<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wang Z</submitter><funding>National Natural Science Foundation of China</funding><pagination>e04552</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12499418</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(37)</volume><pubmed_abstract>Progressive cardiac fibrosis post myocardial infarction (MI) drives pathological remodeling and heart failure, yet the role of endoplasmic reticulum-selective autophagy (ER-phagy) in this process remains unclear. Autocrine Motility Factor Receptor (AMFR) is a recently identified ER-phagy regulator, whose function under myocardial pathology remains poorly understood. Here, it is found that FAM134B-mediated ER-phagy activity is elevated in fibrotic mouse heart tissues post-MI and in cardiac fibroblasts stimulated by TGF-β1. AMFR knockout in mice aggravated cardiac fibrosis post-MI and worsened cardiac function, with scRNA-seq analysis demonstrating that AMFR-null cardiac fibroblasts exhibit a myofibroblast phenotype. Simultaneously, AMFR overexpression in cardiac fibroblasts reduces the expr</pubmed_abstract><journal>Advanced science (Weinheim, Baden-Wurttemberg, Germany)</journal><pubmed_title>ER-phagy Activation by AMFR Attenuates Cardiac Fibrosis Post-Myocardial Infarction via mTORC1 Pathway.</pubmed_title><pmcid>PMC12499418</pmcid><funding_grant_id>82271592</funding_grant_id><pubmed_authors>Jin X</pubmed_authors><pubmed_authors>Li T</pubmed_authors><pubmed_authors>Niu K</pubmed_authors><pubmed_authors>Yang B</pubmed_authors><pubmed_authors>Chen Y</pubmed_authors><pubmed_authors>Lin Y</pubmed_authors><pubmed_authors>Wang X</pubmed_authors><pubmed_authors>Jin Y</pubmed_authors><pubmed_authors>Wang Z</pubmed_authors><pubmed_authors>Liu W</pubmed_authors></additional><is_claimable>false</is_claimable><name>ER-phagy Activation by AMFR Attenuates Cardiac Fibrosis Post-Myocardial Infarction via mTORC1 Pathway.</name><description>Progressive cardiac fibrosis post myocardial infarction (MI) drives pathological remodeling and heart failure, yet the role of endoplasmic reticulum-selective autophagy (ER-phagy) in this process remains unclear. Autocrine Motility Factor Receptor (AMFR) is a recently identified ER-phagy regulator, whose function under myocardial pathology remains poorly understood. Here, it is found that FAM134B-mediated ER-phagy activity is elevated in fibrotic mouse heart tissues post-MI and in cardiac fibroblasts stimulated by TGF-β1. AMFR knockout in mice aggravated cardiac fibrosis post-MI and worsened cardiac function, with scRNA-seq analysis demonstrating that AMFR-null cardiac fibroblasts exhibit a myofibroblast phenotype. Simultaneously, AMFR overexpression in cardiac fibroblasts reduces the expr</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Oct</publication><modification>2026-06-04T04:47:11.078Z</modification><creation>2026-05-05T03:12:39.014Z</creation></dates><accession>S-EPMC12499418</accession><cross_references><pubmed>40673870</pubmed><doi>10.1002/advs.202504552</doi></cross_references></HashMap>